Clinical trial · Observational
Management of Metastatic Breast Cancer in Clinical Practice - Retrospective Study
A Retrospective Cohort Study on Therapeutic Management of Metastatic Breast Cancer in Clinical Practice in Bulgaria
NCT01715155CI-TRIAL-00011823completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the incidence rate of progression of disease, to describe the diagnostic and clinical management in patients with Metastatic Breast Cancer in the clinical practice in Bulgaria.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Metastatic Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Female patients diagnosed with metastatic breast cancer
- description
- Patients newly diagnosed with metastatic breast cancer, either De Novo or having progressed from a non-metastatic stage.
Primary outcomes (1)
- measure
- Number of progression events on a per patient-year-basis
- timeFrame
- Up to 2 years 5 months
Secondary outcomes (3)
- measure
- Proportion of patients among study population who have not progressed at 12 and 18 months after they were diagnosed
- timeFrame
- Up to 2 years 5 months
- measure
- Median and mean time interval that elapsed between diagnosis and first objective tumor progression (TTP) event and subsequent events
- timeFrame
- Up to 2 years 5 months
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * New diagnosis of breast cancer according to ICD-10 with confirmed metastasis * Confirmed diagnosis between 1st July 2010 and 30th June 2011. * Female patient managed for her disease at the same setting where final diagnosis of MBC was performed. Exclusion Criteria: * History of concurrent or other primary malignancies (except curatively resected non-melanoma skin cancer or in situ cervical cancer).
References
Publications (0)
Data not yet available
No reference posted for this study.